View Older Stories View More Recent Stories
-
Form 4 Lazard, Inc. For: Feb 20 Filed by: Gathy Michael
-
Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in January
-
Astellas partners with Vir Biotechnology on prostate cancer treatment
-
Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
-
Form 10-K Lazard, Inc. For: Dec 31
-
Form 497K LAZARD RETIREMENT SERIES
-
Form 497 LAZARD RETIREMENT SERIES
-
Form D/A Lazard ESC US Short Dura
-
Form D/A Lazard ESC US Equity
-
Form D/A Lazard ESC International
-
Form D/A Lazard ESC Global Listed
-
Form D/A Lazard ESC Global Equity
-
Form D/A Lazard ESC Emerging Mark
-
Form D/A Lazard Core Fixed Income
-
Form 4 Lazard, Inc. For: Feb 17 Filed by: Howe Stephen R. Jr.
-
Form 4 Lazard, Inc. For: Feb 17 Filed by: Alper Andrew M
-
Form D/A Lazard Private Market
-
LAZARD EXPANDS ITS HEALTHCARE SERVICES TEAM WITH ADDITION OF JOHN KOSKI AND ROBERT LOWE
-
Form 13F-HR LAZARD ASSET MANAGEMENT For: Dec 31
-
Form 13F-NT LAZARD ASSET MANAGEMENT For: Dec 31
-
Form SCHEDULE 13G ASA Gold & Precious Meta Filed by: LAZARD ASSET MANAGEMENT LLC
-
Form SCHEDULE 13G Brightstar Lottery PLC Filed by: LAZARD ASSET MANAGEMENT LLC
-
Form SCHEDULE 13G DENTSPLY SIRONA Inc. Filed by: LAZARD ASSET MANAGEMENT LLC
-
Form SCHEDULE 13G KOREA FUND INC Filed by: LAZARD ASSET MANAGEMENT LLC
-
Form SCHEDULE 13G MORGAN STANLEY INDIA Filed by: LAZARD ASSET MANAGEMENT LLC
-
Form SCHEDULE 13G Arcos Dorados Holdings Filed by: LAZARD ASSET MANAGEMENT LLC
-
Form SCHEDULE 13G China Fund, Inc. Filed by: LAZARD ASSET MANAGEMENT LLC
-
Form D/A Lazard US Equity Strateg
-
Form D/A Lazard Private Market
-
Form D/A Lazard Long/Short Equity
-
Form D/A Lazard International
-
Form D/A Lazard Hedge Strategies
-
Form D/A Lazard Event Driven Stra
-
Form D/A Lazard Emerging Market
-
Xerox raises $450 million through joint venture with TPG
-
Xerox Raises $450 Million for New Joint Venture to Strengthen Balance Sheet and Support Long-Term Strategy
-
CERo Therapeutics appoints Eric Francois to board of directors
-
CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors
-
Portland General Electric announces acquisition of Washington state utility operations and select assets from PacifiCorp, 2025 financial results and initiates 2026 earnings guidance
-
Analysis-Schroders sale puts more European money managers in play
-
Form D/A Lazard Emerging Markets
-
David Hunt and Kenneth Jacobs to join Vanguard's Board of Directors
-
Investindustrial completes $2.9 billion TreeHouse Foods acquisition
-
Investindustrial Completes Acquisition of TreeHouse Foods
-
LAZARD assets under management rise to $267 billion in January
-
LAZARD REPORTS JANUARY 2026 ASSETS UNDER MANAGEMENT
-
Form 3 Lazard, Inc. For: Feb 01 Filed by: Farr Tracy
-
Eli Lilly to acquire Orna Therapeutics for up to $2.4 billion
-
Lilly to acquire Orna Therapeutics to advance cell therapies
-
Form N-MFP3 LAZARD FUNDS INC For: Jan 31

